Biopharma News
PeopleImages.com - Yuri A Shutterstock
Everest Medicines announces positive results in Phase 1b/2a clinical trial
Everest Medicines has announced positive results in the ongoing Phase 1b/2a clinical trial for the treatment of primary membranous nephropathy (pMN) with EVER001 (previously known as XNW1011). Read more
9 Dec 2024
IMA Life
IMA Life announces partnership with RheaVita
IMA Life has announced a strategic partnership with RheaVita, a pioneer in controlled, continuous freeze-drying technology for biopharmaceuticals. Read more
21 Nov 2024
ustas7777777/Shutterstock
Pheast presents new preclinical data for anti-CD24 macrophage checkpoint inhibitor
Pheast Therapeutics announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage "don't eat me" signal on cancer cells. Read more
12 Nov 2024
Anusorn/Adobe Stock
iotaSciences launches fast single-cell cloning platform for gene therapy
iotaSciences announced the upcoming launch of its newly developed Single-Cell Cloning Platform XT at the Cell 2024 event in London (UK) from November 6-8, 2024. Read more
5 Nov 2024
peterschreiber.media/Adobe Stock
Avantor and NIBRT extend partnership to address biopharma challenges
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex equipment, essential products and expert training to foster innovations in biopharma manufacturing. Read more
24 Oct 2024
herman/Adobe Stock
SynaptixBio calls for genetic screening to include untreatable conditions
The study will offer whole genome sequencing to newborns using their blood samples to test for over 200 rare genetic conditions. Read more
23 Oct 2024
Asahi Kasei
Planova FG1 brings a step forward in biopharma manufacturing
Koki Obara, marketing manager, Asahi Kasei Medical, delves into the current biopharmaceutical environment, the critical role of virus removal filters, and how Planova FG1 stands to impact the development and production of biopharmaceuticals. Read more
3 Dec 2024
Leqembi, Donanemab and Tofersen: The End of the Journey or the First Step on the Road to Reversing Neurodegeneration?
Dr. Peter Hamley, Chief Scientific Officer at Samsara Therapeutics, explores whether developments in therapeutics for neurodegenerative diseases are truly disease modifying or addressing the symptoms of a deeper problem. Read more
16 Aug 2023
R&D revolution: A new paradigm of sourcing and landscaping for the pharma industry
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation. Read more
12 Jul 2023
TierneyMJ / Shutterstock.com
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
GreenOak Shutterstock
How Adragos is building a more resilient pharma supply chain
The global pharmaceutical industry is facing unprecedented supply chain challenges in the current climate of geopolitical uncertainty. Marco Gorgas, chief technical officer, Adragos Pharma explains. Read more
20 Dec 2024
Pharma Manufacturing News + Pharmaceutical Logistics & Distribution News
BOY ANTHONY Shutterstock
Neuraxpharm and Pharmathen enter into strategic co-development agreement
Neuraxpharm Group (Neuraxpharm) and Pharmathen have announced a strategic alliance to co-develop new long-acting injectable therapies within the psychiatry field under Pharmathen’s long-acting therapeutic technologies (LATT) program. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
PeopleImages.com - Yuri A Shutterstock
NEC announces interim results from Phase 1 clinical trial
NEC Bio Therapeutics presents 24-week promising interim results from an ongoing Phase 1 basket clinical trial of an orally administered cancer vaccine, NECVAX-NEO1. Read more
20 Dec 2024
Pharma Manufacturing News + New Drug Development & Regulatory News
Freudenberg
Freudenberg Sealing Technologies enhances safety of modern lithium-ion batteries
Freudenberg Sealing Technologies is working on enhancing the safety of modern lithium-ion batteries, thereby advancing the future of electromobility. Read more
20 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Ahmed Hamaki Shutterstock
Mary Marcus appointed CEO of NewAge Industries
NewAge Industries, parent company of AdvantaPure and NewAge Performance Products, has announced the appointment of Mary Marcus to the position of CEO. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Phastar
Phastar scoops 2024 Scrip Award
Phastar, a specialist biometrics contract research organisation (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards. Read more
19 Dec 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
